Replies to post #1394 on Vascular Biogenics Ltd (VBLT)

[staccani]

Oren, most likely will not be stopped early, because we are very close to trial end and because it would need a FDA approval to stop it early.
But I agree, I would not be surprised if it is stopped early and the delay in the announcement of DMSC review leads me to believe at least some discussions are probably ongoing behind the scenes